What happens at relapse
Relapse is the return of leukemia after remission. When it happens, the team reassesses the situation and builds a new plan.

01Short answer
02Simple explanation
A return. Hidden cells grow again.
Confirmation. Bone marrow and genetic tests are repeated.
Reassessment. The team considers every factor.
A new plan. There may be several treatment paths.
03Scientific explanation
Types of relapse: haematological (blasts rising again in the marrow), molecular or MRD relapse (seen only on sensitive tests), and extramedullary (CNS, testis, skin). The length of remission is an important prognostic sign: early relapse usually points to more resistant disease.
Clonal evolution: at relapse, mutations may appear or disappear (such as FLT3 and IDH1/2 in AML, or ABL1 kinase domain mutations in CML), so a repeat genetic profile is needed to choose targeted drugs. In B-ALL, CD19 or CD22 expression affects the choice of immunotherapy.
Treatment principles: the aim is often to regain remission and, where suitable, proceed to allogeneic transplant; for relapse after transplant, reducing immunosuppression, donor lymphocyte infusion or a second transplant may be considered. Palliative support can be offered alongside at any stage.
04What happens in the body?
Why does relapse happen?
Even the most sensitive tests cannot find every cell. A small number of cells that survive treatment can grow again over time.
Several paths
Treatment after relapse is personal. The team should openly discuss the benefits and risks of each path with you.

Support matters
This news brings strong feelings. Talking with family, friends, a psychologist and patient organisations can lighten the load.

05Steps after relapse
A simplified outline.







06Possible options after relapse
| Option | Example | Note |
|---|---|---|
| Chemotherapy | Re-induction | Depends on previous treatment |
| Targeted drugs | FLT3, IDH, BCR-ABL inhibitors | Based on genetic results |
| Immunotherapy | Antibodies, CAR-T | Mainly ALL and some other types |
| Transplant | Allogeneic | After remission, if suitable |
| Clinical trial | New medicines | Depends on the centre |
| Palliative support | Symptom control | Alongside, at any stage |
* Only your treating team, together with you, decides which option fits.
07Key terms
- Relapse
- Return of disease after remission.
- Molecular relapse
- Disease seen only on sensitive tests.
- Extramedullary
- Outside the bone marrow.
- Clonal evolution
- New changes arising in leukemia cells.
- CAR-T
- Treatment with specially prepared T cells.
- Second opinion
- The view of another specialist.
08Key points
- Relapse is hard news, but there are options.
- Relapse is confirmed with repeat tests.
- Genetic tests can open new paths.
- The plan is personal and made together.
- You have the right to a second opinion.
- Emotional support is part of treatment.
09Frequently asked questions
Is relapse my fault?
No. Relapse comes from the biology of the leukemia cells, not from anything you did or didn’t do.
Is remission possible again?
In many cases yes; your doctor will give you specific information about your chances.
How can I join a clinical trial?
Ask your doctor about suitable trials; sometimes referral to another centre is needed.
How do I tell my children?
Simple, honest, age-appropriate words are advised; a psychologist can help.
10Questions for your doctor
Take these questions to your appointment. The ones you save are collected on the “My questions” page and stay on this device only.
Is relapse my fault?
Is remission possible again?
How can I join a clinical trial?
How do I tell my children?
12Sources
- National Cancer Institute (NCI). Adult Acute Myeloid Leukemia Treatment (PDQ) – Patient Version
- National Cancer Institute (NCI). Adult Acute Lymphoblastic Leukemia Treatment (PDQ) – Patient Version
- National Cancer Institute (NCI). Definition of relapse – NCI Dictionary of Cancer Terms
- National Cancer Institute (NCI). Follow-Up Medical Care
- American Cancer Society. Treating Acute Myeloid Leukemia (AML)
- Cancer Research UK. Treatment for acute lymphoblastic leukaemia (ALL)
- NHS. Acute lymphoblastic leukaemia: Treatment
- Leukemia & Lymphoma Society. ALL treatment
- Cancer Research UK. Types of acute lymphoblastic leukaemia (ALL)
- Leukemia & Lymphoma Society. ALL subtypes